Safety of High Doses of Recombinant Human Growth Hormone

Publisher： Karger

E-ISSN： 1663-2826|49|2|78-81

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.49, Iss.2, 2004-11, pp. : 78-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study

By  

Hormone Research in Paediatrics, Vol. 72, Iss. 6, 2009-10 ,pp. : 359-369

Karger

Access to resources Recommend Favorite

Use of Recombinant Human Growth Hormone in Children with Thalassemia

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2009-01 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

Management of Recombinant Human Growth Hormone Therapy at Puberty

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 2, 2004-11 ,pp. : 58-61

Karger

Access to resources Recommend Favorite

A Randomised Study of Two Doses of Biosynthetic Human Growth Hormone on Final Height of Pubertal Children with Growth Hormone Deficiency

By  

Hormone Research in Paediatrics, Vol. 70, Iss. 2, 2008-06 ,pp. : 85-88

Karger

Access to resources Recommend Favorite

Treatment of Growth Hormone-Deficient Infants with Recombinant Human Growth Hormone to Near-Adult Height: Patterns of Growth

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 4, 2011-01 ,pp. : 276-283

Karger

Access to resources Recommend Favorite